GU07-123

• Research type

  Research Study

• Full title

  PHASE II TRIAL OF NEOADJUVANT CISPLATIN, GEMCITABINE AND SUNITINIB MALATE FOLLOWED BY RADICAL CYSTECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER

• IRAS ID

  8304

• Contact name

  Barts-CTU

• Sponsor organisation

  Hoosier Oncology group

• Eudract number

  2008-006214-26

• ISRCTN Number

  IRAS

• Research summary

  N/A

• REC name

  London - Central Research Ethics Committee

• REC reference

  09/H0718/46

• Date of REC Opinion

  7 Sep 2009

• REC opinion

  Favourable Opinion